Cargando...
MEK inhibitors: a new class of chemotherapeutic agents with ocular toxicity
A new class of chemotherapeutic agents, MEK inhibitors, has recently been developed and is proving to be an effective treatment for a number of cancers. A pattern of ocular adverse events has followed these drugs through clinical trials and their association with retinopathy is only just beginning t...
Gardado en:
| Publicado en: | Eye (Lond) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Nature Publishing Group
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4541356/ https://ncbi.nlm.nih.gov/pubmed/26043707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2015.82 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|